New York, USA – July 13, 2022 – Liposomes have been widely used as novel drug carriers in the pharmaceutical field by virtue of low immunogenicity, low toxicity, strong targeting efficiency, and good biocompatibility with human bodies. Liposomes are now mainly applied to anti-cancer drugs, gene therapy, vaccine development, and active targeting agents.
In recent years, liposomes have become one of the most rapidly developed drug formulations. Due to the COVID-19 pandemic, liposome drug development has attracted even greater attention. In terms of clinical research progress, it is foreseeable that more liposome drugs will be presented. According to statistics, the global liposome drug market has reached 3.3 billion USD in 2021 and is expected to reach 6.5 billion USD in 2028.
• Liposome Development Service
Liposomes are highly biocompatible and controllable in vivo and can be loaded with a broad range of drugs, DNA, and diagnostic agents.
Creative Biolabs offers a range of liposome custom services, including functional liposome development, liposomal formulation development, as well as liposome analysis and characterization. A variety of novel liposome formulations, such as proteoliposomes, immunoliposomes, magnetic liposomes, fluorescent liposomes, and pH-sensitive liposomes, are also available at Creative Biolabs.
Creative Biolabs provides liposomes that are non-toxic, biocompatible, and fully biodegradable, which can effectively improve drug efficacy and stability, reduce drug toxicity, and enhance flexibility for active targeting.
• Custom Lipid Synthesis Service
Lipids commonly used to form nanocarriers are amphiphilic molecules with hydrophilic heads and hydrophobic fatty acid tails.
Creative Biolabs’ featured services for custom lipid synthesis include head group modification, fatty acid chains modification, purification, and analysis.
In addition, Creative Biolabs is able to design and synthesize other macroscopic amphiphilic molecules via conjugation, such as amphiphilic polymers, polymer-peptide conjugates, polymer-lipid conjugates, and drug-lipid conjugates, which can form micellar structures and act as controlled release drug carriers.
• One-stop Liposome Research Solution
With years of experience in liposome development, Creative Biolabs is able to prepare liposomes of different sizes, structures, or functions by a variety of methods based on the advanced LipoDrive™ platform. This newly launched one-stop liposome development service platform covers all phases of liposome-based research, supporting high-quality liposome design and preparation, related in vitro and/or in vivo experiments, as well as liposome-related drugs (antibodies, peptides, mRNA, plasmids, etc.).
Explore more information about liposome custom services and products at https://www.creative-biolabs.com/lipid-based-delivery.
About Creative Biolabs
With over ten years of experience in liposome development, Creative Biolabs is dedicated to providing liposome products and services that can meet the highest standards and fulfill various requirements.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/lipid-based-delivery
